Keya Medical

AI for Smarter Healthcare

Calantic-KeyaMedical-ECR24

Don't miss this opportunity to experience the potential of AI in radiology.

Join us at ECR2024 to witness the potential of AI in cardiology firsthand!
Keya Medical is thrilled to showcase its AI-based augmented CT-FFR analysis through Bayer’s Calantic Digital Solutions platform. Discover more about the Calantic AI platform and Keya Medical’s cardiac service at the Bayer Booth (X1- AI 01).

Diagnostic Solutions

Treatment Solutions

Solution Suites

Cardiology

Neurology

Pulmonology

Pathology

General Surgery

Cardio Suite

Stroke Suite

Diagnostic Solutions

Cardiology

Neurology

Pulmonology

Pathology

Treatment Solutions

Vascular Surgery

General Surgery

Solutions Suites

Cardio Suite

Stroke Suite

DeepVessel® FFR

Enabling better diagnosis and treatment of patients with coronary artery disease.

DeepVessel Certification 2020

DEEPVESSEL FFR uses deep learning technology to perform a non-invasive physiological functional assessment of the coronary arteries using coronary computer tomography angiograms. The software can reduce unnecessary invasive testing, improve patient safety, and lower the cost of cardiovascular testing.

DEEPVESSEL FFR is FDA Cleared, CE Marked, and NMPA Approved.

FFRCT and DVFFR have transformed my practice, allowing me to provide superior patient care and achieve better outcomes. I am sincerely grateful for this invaluable resource provided by Corazon Imaging.

John A. Rumberger, PhD, MD, FACC, MSCCT

Medical Director, Corazon Imaging

Scaling your Cardiovascular CT Service and Implementing CT-FFF

Discover the power of automated CT-FFR integration in enhancing your cardiovascular CT services. Learn from Dr. John A Rumberger, Dr. Scott Flamm, and Ralph Gentry how to simplify CT FFR implementation and scale your services.

Comprehensive R&D Pipeline Solution Suites

Keya Medical Comprehensive Solutions

Keya Medical is developing a comprehensive R&D pipeline to deliver clinical value throughout the patient care process. The product candidates in our pipeline will be designed for use in early screening, diagnosis, treatment, and post-treatment followup.

Keya Medical: world’s leading AI medical device company

Keya Medical is an international medical technology company developing deep learning-based medical devices for disease diagnosis and treatment. The company is committed to creating solutions that deliver clinical value at all stages in the patient care process, covering specialties including cardiology, neurology, pulmonology, pathology, and surgery. Keya Medical has four centers of excellence in Beijing, Shanghai, Shenzhen, and Seattle. To learn more about Keya Medical, follow us on LinkedInTwitter, and Facebook.

Latest News

Subscribe to our monthly newsletter to receive exclusive news updates and medical AI insights.

Let’s transform the future of healthcare together